Cern Corporation, Inc. / CernDevice.com.  Our focus is on Women’s Health. Cern has developed the use of low level, visible spectrum, microbicidal light as a safe and effective treatment of both yeast & bacterial GYN infection, including drug resistant pathogen.  Our approach focuses on three key areas.
Affective Therapeutic: Cern’s approach addresses challenges to systemic drugs. We have shown safety and efficacy on both yeast and bacterial microbes including drug resistant.
Anti-Microbial Resistance: Cern’s approach does not contribute to microbe resistance.
Birthrate: The ability to mitigate bacterial vaginosis in a safe effective manner, without drugs, holds promise to improve conception rates as well as healthy full-term gestation.


Cern Device

Org chart

Teams

Offices

Cern Device

Org chart

Teams

Offices

Related companies